A detailed history of Virtus Fund Advisers, LLC transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Virtus Fund Advisers, LLC holds 2,630 shares of ANIK stock, worth $45,183. This represents 0.32% of its overall portfolio holdings.

Number of Shares
2,630
Previous 2,630 -0.0%
Holding current value
$45,183
Previous $66,000 3.03%
% of portfolio
0.32%
Previous 0.26%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$24.57 - $28.47 $1,744 - $2,021
71 Added 2.77%
2,630 $66,000
Q1 2024

May 15, 2024

BUY
$21.95 - $26.42 $56,170 - $67,608
2,559 New
2,559 $64,000
Q4 2022

Feb 14, 2023

BUY
$23.85 - $31.91 $83,236 - $111,365
3,490 New
3,490 $103,000

Others Institutions Holding ANIK

About Anika Therapeutics, Inc.


  • Ticker ANIK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,599,900
  • Market Cap $251M
  • Description
  • Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...
More about ANIK
Track This Portfolio

Track Virtus Fund Advisers, LLC Portfolio

Follow Virtus Fund Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus Fund Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus Fund Advisers, LLC with notifications on news.